Frontier Medicines

Frontier Medicines

  • Founded: 2018
  • Location: South SF, CA
  • Employee range: 11 - 50
  • Clinical stage: Clin0
  • Therapy area: Oncology
  • Drug types: ONC
  • Lead product: FMC-376
  • Product link:
  • Funding: $88.5M B Jul 2021; $67M A Jun 2019
  • Investors: Deerfield Management, Droia Oncology Ventures, MPM Capital

job board

Short description:

Drug Discovery Using Chemoproteomics Platform

Drug notes:

7 additional undisclosed programs RD oncology

Long description:

Frontier Medicines is generating medicines to treat previously undruggable disease-causing targets. Chemoproteomics is an approach to understand the interaction between small molecules and proteins in cellular contexts. Frontier is using their proprietary platform, powered by chemoproteomics along with covalent chemistry and machine learning to accelerate the discovery and development of precision medicines. The platform uses insights from proteome screening in disease relevant systems along with proprietary techniques and algorithms enabling rapid identification and assessment of actionable leads for undruggable targets. Frontier is using their platform to build a pipeline of precision medicines initially focused on oncology.


Frontier Medicines
Principal Scientist/Associate Director, Process Ch...
South San Francisco, CA|4 days ago
Frontier Medicines
Principal Scientist/Associate Director, Process Ch...
Boston, MA|5 days ago
Frontier Medicines
Senior Scientist/Principal Scientist, Computationa...
Boston, Massachusetts, Stati Uniti d'America|13 days ago
Frontier Medicines
Sr. Manager/Associate Director, CMC Development
South San Francisco, California, Stati Uniti d'America|15 days ago

© 2024 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy